Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNRx Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.70 | -$0.70 | -$0.70 |
| Q2 2024 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q3 2024 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q1 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2025 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2025 | 1 | $0.10 | $0.10 | $0.10 |
| Q4 2025 | 1 | $0.16 | $0.16 | $0.16 |
| Q1 2026 | 1 | $0.26 | $0.26 | $0.26 |
| Q2 2026 | 1 | $0.28 | $0.28 | $0.28 |
| Q3 2026 | 1 | $0.28 | $0.28 | $0.28 |
| Q4 2026 | 1 | $0.29 | $0.29 | $0.29 |
| Q1 2027 | 1 | $0.97 | $0.97 | $0.97 |
| Q2 2027 | 1 | $1.01 | $1.01 | $1.01 |
| Q3 2027 | 1 | $1.01 | $1.01 | $1.01 |
| Q4 2027 | 1 | $1.05 | $1.05 | $1.05 |
| Q1 2028 | 1 | $2.09 | $2.09 | $2.09 |
| Q2 2028 | 1 | $2.17 | $2.17 | $2.17 |
| Q3 2028 | 1 | $2.17 | $2.17 | $2.17 |
| Q4 2028 | 1 | $2.26 | $2.26 | $2.26 |
NRx Pharmaceuticals, Inc. Earnings Date And Information
NRx Pharmaceuticals, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.75 earnings per share for the quarter, topping analysts' consensus estimates of $-0.81 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NRx Pharmaceuticals, Inc. has generated $-4 earnings per share over the last year ($-3.98 diluted earnings per share) and currently has a price-to-earnings ratio of -0.76. NRx Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
NRx Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.15 | $0 | $0 | ||
| 08/14/2024 | Q2 2024 | -$0.81 | -$0.75 | 0.06 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.55 | -$0.74 | -0.19 | $0 | |
| 04/29/2024 | Q4 2023 | -$0.05 | $8,000 | |||
| 09/29/2023 | Q3 2023 | -$0.07 | $0 | |||
| 08/14/2023 | Q2 2023 | -$1.40 | -$0.12 | 1.28 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.19 | $0 | |||
| 05/01/2023 | Q4 2022 | -$0.09 | $0 | |||
| 11/14/2022 | Q3 2022 | -$1.40 | -$0.14 | 1.26 | $0 | |
| 08/15/2022 | Q2 2022 | -$1.00 | -$0.07 | 0.93 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.18 | $0 | |||
| 03/31/2022 | Q4 2021 | -$0.60 | $0 | |||
| 11/15/2021 | Q3 2021 | -$0.38 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.38 | $0 | |||
| 05/20/2021 | Q1 2021 | -$0.71 | $0 | |||
| 04/01/2021 | Q4 2020 | -$16.73 | $0 | |||
| 11/16/2020 | Q3 2020 | -$0.14 | $0 | |||
| 08/14/2020 | Q2 2020 | $0.00 | $0 | |||
| 05/15/2020 | Q1 2020 | -$0.15 | $0 | |||
| 03/30/2020 | Q4 2019 | -$0.16 | $0 |
NRx Pharmaceuticals, Inc. Earnings: FAQ's
When is NRx Pharmaceuticals, Inc.'s earnings date?
NRx Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
Did NRx Pharmaceuticals, Inc. beat their earnings estimates last
quarter?
In the previous quarter, NRx Pharmaceuticals, Inc. (:NRXP) reported $-0.75 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.81 by $0.06.
How can I listen to NRx Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for NRx Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read NRx Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for NRx Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much profit does NRx Pharmaceuticals, Inc. generate each year?
NRx Pharmaceuticals, Inc. (:NRXP) has a recorded net income of $0. NRx Pharmaceuticals, Inc. has generated $-3.98 earnings per share over the last four quarters.
What is NRx Pharmaceuticals, Inc.'s price-to-earnings ratio?
NRx Pharmaceuticals, Inc. (:NRXP) has a price-to-earnings ratio of -0.76 and price/earnings-to-growth ratio is 0.18.